Merck nears $10 billion deal for respiratory drugmaker Verona, FT reports
(Reuters) -Merck is nearing a roughly $10 billion deal to buy lung disease-focused biotech Verona Pharma, the Financial Times reported ...
Read moreDetails(Reuters) -Merck is nearing a roughly $10 billion deal to buy lung disease-focused biotech Verona Pharma, the Financial Times reported ...
Read moreDetails
